To study the impact of HCI‐2509 on KRAS‐mutated adenocarcinoma in vivo, we used C57BL/6N(KRAS G12V) mice, in which the constitutively active KRAS form is induced via adenoviral Cre application. This evidence concerns the gene KRAS and adenocarcinoma.